Consequently, several critical gaps remain concerning tau expression in the marmoset and its relevance to AD: specifically, age‐dependent alterations of tau isoform expression and phosphorylation residues related to pathological tau aggregation, as well as the subcellular distribution of tau in the marmoset brain, which have yet to be comprehensively investigated. Here, MAPT is linked to Alzheimer disease.